Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abbott Laboratories (NY: ABT ) 117.76 +0.50 (+0.43%) Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 5,349,788 Open 117.22 Bid (Size) 117.76 (1) Ask (Size) 117.98 (1) Prev. Close 117.26 Today's Range 116.38 - 118.00 52wk Range 99.71 - 121.64 Shares Outstanding 1,750,942,289 Dividend Yield 1.87% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 2 Dividend Kings to Buy for a Lifetime of Passive Income November 22, 2024 Via The Motley Fool What To Do After The Worst Week For Healthcare Stocks Since March 2020? November 19, 2024 The market was quiet today but we should still expect some gains through year -end albeit a bit choppy. Via Talk Markets Performance YTD +7.20% +7.20% 1 Month +1.05% +1.05% 3 Month +4.49% +4.49% 6 Month +15.51% +15.51% 1 Year +14.47% +14.47% More News Read More Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids November 15, 2024 Via Benzinga 3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years November 14, 2024 Via The Motley Fool Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues November 08, 2024 Via Investor's Business Daily 2 Dividend Kings That Would Have Doubled Your Money in 5 Years November 08, 2024 Via The Motley Fool Analyst Ratings For Abbott Laboratories November 05, 2024 Via Benzinga Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial November 01, 2024 Via Investor's Business Daily P/E Ratio Insights for Abbott Laboratories October 22, 2024 Via Benzinga Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever November 08, 2024 Via The Motley Fool What You Missed On Wall Street This Past Friday November 03, 2024 Via Talk Markets AbbVie’s Dividend Isn’t As Scary As It Looks October 30, 2024 Via Talk Markets These Are The Top Health Stocks to Own for Buy-and-Hold Investing October 30, 2024 Via MarketBeat Exposures COVID-19 Is Abbott Laboratories Stock a Buy? October 17, 2024 Via The Motley Fool 3 Dividend Growth Stocks You Can Buy and Hold Forever October 26, 2024 Via The Motley Fool Beat the Nasdaq With This Cash-Gushing Dividend Stock October 23, 2024 Via The Motley Fool Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever October 19, 2024 Via The Motley Fool MarketBeat Week in Review – 10/14 - 10/18 October 19, 2024 Via MarketBeat Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review October 18, 2024 Via Investor's Business Daily Topics Stocks Exposures US Equities 3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now October 18, 2024 Via The Motley Fool Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic October 17, 2024 Via Benzinga These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings October 17, 2024 Via Benzinga AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories October 17, 2024 Via Benzinga Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday October 17, 2024 Via Benzinga Why Abbott Laboratories Stock Was a Winner on Wednesday October 16, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.